Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed Aug 14, 2024 · 10-Q · 45 days after period end · 0001493152-24-031995
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$209.84K | -$6.76M | $16.01M | -$3.23M |
| EPS Diluted | $0.00 | — | $0.04 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 14, 2024 · 45 d after period end
